Table 5 Proportion of organisms susceptible to each antimicrobial tested. Less prevalent organisms have been grouped by class and missing data are not presented here. Full organism-specific data, including missing values, are available in the supplementary data (Additional file 2)
Susceptibility | N | E. coli, N = 40a | Klebsiella pneumoniae, N = 36a | Other Enterobacterales, N = 11a | Pseudomonas aeruginosa, N = 6a | Acinetobacter spp., N = 7a | Staphylococcus aureus, N = 14a | Streptococcus spp., N = 6a | Enterococcus spp., N = 2a |
|---|---|---|---|---|---|---|---|---|---|
Ceftriaxone | 86 | 6 (19%) | 9 (31%) | 4 (50%) | 1 (33%) | 1 (20%) | 0 (0%) | 1 (25%) | 0 (0%) |
Amikacin | 87 | 32 (91%) | 25 (89%) | 11 (100%) | 6 (100%) | 5 (71%) | 0 (NA%) | 0 (NA%) | 0 (NA%) |
Imipenem | 83 | 31 (97%) | 27 (84%) | 6 (86%) | 5 (83%) | 1 (20%) | 0 (NA%) | 0 (0%) | 0 (NA%) |
Ceftazidime | 37 | 2 (15%) | 2 (15%) | 1 (50%) | 2 (40%) | 0 (0%) | 0 (NA%) | 0 (NA%) | 0 (NA%) |
Polymyxin B | 48 | 13 (81%) | 12 (67%) | 5 (71%) | 3 (100%) | 3 (75%) | 0 (NA%) | 0 (NA%) | 0 (NA%) |
Piperacillin-tazobactam | 70 | 19 (68%) | 17 (65%) | 4 (57%) | 4 (100%) | 2 (40%) | 0 (NA%) | 0 (NA%) | 0 (NA%) |
Gentamicin | 72 | 12 (46%) | 11 (42%) | 4 (50%) | 2 (33%) | 1 (25%) | 2 (100%) | 0 (NA%) | 0 (NA%) |
Ciprofloxacin | 20 | 3 (30%) | 4 (67%) | 0 (NA%) | 1 (100%) | 0 (0%) | 2 (100%) | 0 (NA%) | 0 (NA%) |
Co-amoxiclav | 84 | 1 (2.7%) | 1 (3.1%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (NA%) | 0 (0%) | 1 (100%) |
Cefotaxime | 40 | 7 (44%) | 3 (21%) | 2 (40%) | 0 (0%) | 0 (0%) | 0 (NA%) | 2 (100%) | 0 (NA%) |
Cloxacillin | 1 | 0 (NA%) | 0 (NA%) | 0 (NA%) | 0 (NA%) | 0 (NA%) | 0 (NA%) | 1 (100%) | 0 (NA%) |
Clindamycin | 21 | 0 (NA%) | 0 (NA%) | 0 (NA%) | 0 (NA%) | 0 (NA%) | 9 (69%) | 5 (83%) | 0 (0%) |
Doxycycline | 2 | 0 (NA%) | 0 (NA%) | 0 (NA%) | 0 (NA%) | 0 (NA%) | 1 (100%) | 1 (100%) | 0 (NA%) |
Vancomycin | 20 | 0 (NA%) | 0 (NA%) | 0 (NA%) | 0 (NA%) | 0 (NA%) | 13 (100%) | 5 (100%) | 2 (100%) |
Penicillin | 19 | 0 (NA%) | 0 (NA%) | 0 (NA%) | 0 (NA%) | 0 (NA%) | 1 (7.1%) | 2 (50%) | 0 (0%) |
Chloramphenicol | 31 | 3 (75%) | 9 (90%) | 4 (67%) | 1 (33%) | 0 (0%) | 4 (80%) | 0 (NA%) | 0 (NA%) |
Amoxicillin | 5 | 0 (NA%) | 0 (NA%) | 0 (NA%) | 0 (NA%) | 0 (NA%) | 0 (0%) | 1 (33%) | 0 (NA%) |
Oxacillin | 14 | 0 (NA%) | 0 (NA%) | 0 (NA%) | 0 (NA%) | 0 (NA%) | 12 (100%) | 0 (0%) | 0 (0%) |
Erythromycin | 13 | 0 (NA%) | 0 (NA%) | 0 (NA%) | 0 (NA%) | 0 (NA%) | 6 (60%) | 3 (100%) | 0 (NA%) |
Cefuroxime | 3 | 0 (NA%) | 0 (NA%) | 0 (NA%) | 0 (NA%) | 0 (NA%) | 2 (100%) | 0 (NA%) | 0 (0%) |
Tetracycline | 5 | 0 (NA%) | 0 (NA%) | 0 (NA%) | 0 (NA%) | 0 (NA%) | 1 (33%) | 1 (100%) | 0 (0%) |
Pefloxacin | 11 | 2 (40%) | 1 (50%) | 1 (100%) | 0 (NA%) | 0 (0%) | 0 (0%) | 0 (NA%) | 0 (NA%) |
Nitrofurantoin | 3 | 1 (33%) | 0 (NA%) | 0 (NA%) | 0 (NA%) | 0 (NA%) | 0 (NA%) | 0 (NA%) | 0 (NA%) |
Mecillinam | 1 | 0 (0%) | 0 (NA%) | 0 (NA%) | 0 (NA%) | 0 (NA%) | 0 (NA%) | 0 (NA%) | 0 (NA%) |
Co-trimoxazole | 8 | 0 (0%) | 0 (0%) | 0 (0%) | 0 (NA%) | 0 (NA%) | 0 (NA%) | 0 (NA%) | 0 (NA%) |